Structure Therapeutics
Developing accessible oral small molecule therapies for the treatment of chronic diseases including obesity.
South San Francisco, United States
219 employees
IPO
Total: $1.79B
Biotechnology, Health Care +1
General Information
South San Francisco, United States
BounceWatch is an independent company data service, not affiliated with Structure Therapeutics. To contact Structure Therapeutics, visit structuretx.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Structure Therapeutics compare?
A PDF of Structure Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Structure Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About Structure Therapeutics
Business keywords: Life-changing Medicines, Computational Chemistry, Structure-based Technology, Clinical-stage Pipeline, Chronic Diseases, Biologic and Peptide Drugs, Drug Design, Biological Targets, Global Drug Discovery, Metabolic Diseases, Cardiovascular Diseases, Pulmonary Conditions, Diabetes, Obesity, Data Integration
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post-IPO Equity | $650.00M | - |
|
01 Dec 2025 |
| Post-IPO Equity | $476.00M | - |
|
01 Jun 2024 |
| Private Placement VC | $300.00M | - |
|
01 Sep 2023 |
| IPO | $185.00M | - |
|
01 Feb 2023 |
| Series B | $33.00M | 2 |
|
01 Aug 2022 |
| Series B | $100.00M | 8 |
|
01 Oct 2021 |
| Series A | $26.00M | 2 |
|
01 Mar 2020 |
| Series A | $16.00M | 1 |
|
01 Apr 2019 |
Latest News
View All
Structure Therapeutics Alternatives & Competitors
View All Alternatives
We develop breakthrough medicines for patients through precision small molecule design.
Jnana Therapeutics is a clinical-stage biotechnology company leveraging its next-generation chemopro...
Delivering Peptide Enabled Drug Discovery Solutions
AN2 Therapeutics
FAQ About Structure Therapeutics
Source: BounceWatch company record for Structure Therapeutics, https://bouncewatch.com/company/structure-therapeutics, updated 9 June 2026. When citing, please name BounceWatch and link this page.
